Nachrichten zur Johnson Matthey PLC Aktie

Johnson & Johnson: A Clean Bill Of Health

…

Johnson & Johnson Stock Has 33% Upside, According to 1 Wall Street Analyst

Managements thesis regarding the spinoff is now being tested.…

Expecting a Market Downturn? Protect Your Portfolio With These Dividend Champions

Stocks Analysis by Investing.com (Damian Nowiszewski) covering: Exxon Mobil Corp, Johnson & Johnson, Johnson & Johnson Co, Exxon Mobil Corporation.…

If You Invested $10,000 in Johnson & Johnson Stock in 2004, This Is How Much You Would Have Today

…

If You Invested $10,000 in Johnson & Johnson Stock in 2004, This Is How Much You Would Have Today @themotleyfool #stocks $JNJ

Johnson & Johnson has been a stalwart in the healthcare industry for decades, but has it made for a good…

If You Invested $10,000 in Johnson & Johnson Stock in 2004, This Is How Much You Would Have Today

Johnson & Johnson has been a stalwart in the healthcare industry for decades, but has it made for a good…

If You Invested $10,000 in Johnson & Johnson Stock in 2004, This Is How Much You Would Have Today

Johnson & Johnson has been a stalwart in the healthcare industry for decades, but has it made for a good…

Johnson & Johnson wins FDA nod for first frostbite therapy

…

Johnson & Johnson: A High-Quality Dividend King Facing Furious Headwinds

…

Top Research Reports for Johnson & Johnson, Walt Disney & Uber

Todays Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), The Walt Disney Company…

Pharma Stocks: 5 Biggest Companies in 2024

The pharmaceutical industry is a major player in the life science sector, responsible for developing and manufacturing the majority of…

Is Johnson & Johnson a Good Dividend Stock to Buy Now? @themotleyfool #stocks $JNJ

The healthcare conglomerate has been raising its dividend payout since Kennedy was president, but there have been some recent changes.…

[Latest] Global Medical Implant Market Size/Share Worth USD 203.6 Billion by 2032 at a 6.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…

Johnson & Johnson: Medtech-Momentum & GLP-Risiko am Horizont - Aktienanalyse

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…

Johnson & Johnson: Positioned To Receive Benefits Of Heavy R&D Investments

…

Better Growth Stock: UnitedHealth Group vs. Johnson & Johnson

These companies have been focusing on growing their operations, but which stock is likely to provide investors with better returns?…

Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices

The CEOs of Merck, Johnson & Johnson and Bristol Myers Squibb will testify at the hearing on drug prices, Sen.…

Better Dividend Stock to Buy Now: Johnson & Johnson vs. Verizon

Both recently reported results from the fourth quarter of 2023 and their performances could hardly look more different.…

Better Dividend Stock to Buy Now: Johnson & Johnson vs. Verizon @themotleyfool #stocks $VZ $JNJ

Both recently reported results from the fourth quarter of 2023 and their performances could hardly look more different.…

Auslandsaktien: „Zweite und dritte Reihe könnte nachziehen“

Die US-Berichtssaison ist in vollem Gange. Für die großen US-Tech-Werte, die „Magnificant Seven“, gibt es eine Menge Vorschusslorbeeren. Unternehmen aus…

3M mit schwachem Ausblick - Auch GE-Ausblick enttäuscht - United Airlines zeigt sich optimistisch

Wien (www.aktiencheck.de) - Johnson & Johnson (ISIN: US4781601046, WKN: 853260, Ticker-Symbol: JNJ, NYSE-Symbol: JNJ) (-1,6%) konnte im Vorjahr mit einem…

Proctor & Gambles Wachstum verlangsamt sich - Johnson & Johnson profitiert von Abspaltung der Konsumgütersparte

Konsumgüterriese Proctor&Gamble wächst weniger stark als erwartet. Johnson & Jonson schließt Geschäftsjahr 2023 stärker als prognostiziert.Im letzten Quartal des Jahres…

J&J’s Spravato success confirms commercial viability of psychedelics for mental health

The commercial success of Johnson & Johnson (NYSE:JNJ)s esketamine nasal spray Spravato for use in treatment-resistant depression and major depressive...…

Johnson & Johnson to settle talc baby powder investigation, will reportedly pay $700 million

The settlement does not resolve the tens of thousands of lawsuits alleging that J&Js talc-based products caused cancer.…

Johnson & Johnson (JNJ) Q4 2023 Earnings Call Transcript

JNJ earnings call for the period ending December 31, 2023.…

Johnson & Johnson 2023 Q4 - Results - Earnings Call Presentation

…

Johnson & Johnson (JNJ) Q4 2023 Earnings Call Transcript

…

Johnson & Johnson mit guten Zahlen - Prognose steht

In den USA nimmt die Berichtssaison allmählich an Fahrt auf. Am Dienstag hat auch Johnson & Johnson frische Zahlen zum…

Johnson & Johnson mit guten Zahlen – Prognose steht

In den USA nimmt die Berichtssaison allmählich an Fahrt auf. Am Dienstag hat auch Johnson & Johnson frische Zahlen zum…

Johnson & Johnson undershoots full-year earnings guidance

New Jersey-based pharmaceutical giant Johnson & Johnson (NYSE:JNJ) hit top-line expectations in today’s annual earnings call, but slightly undershot with...…

Johnson & Johnson: MedTech als Wachstumsmotor - Aktienanalyse

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…

Johnson & Johnson holds 2024 profit forecast steady after solid Q4 earnings

Johnson & Johnson says its on track to meet its 2025 target of $57 billion in pharmaceutical sales.…

Johnson & Johnson in charts: MedTech segment sales surged 13% Y/Y in Q4

…

Johnson & Johnson Q4 earnings beat estimates amid strength in medtech

…

Johnson & Johnson tops revenue estimates, reiterates forecast By Investing.com

Johnson & Johnson tops revenue estimates, reiterates forecast…

Johnson & Johnson narrowly tops quarterly estimates as pharmaceutical, medtech sales jump

The results come six months after J&J completed its spinoff of consumer health unit Kenvue, the companys biggest shake-up in…

Surgical Dressing Market Valuation to Reach US$1.9 Billion by 2030, Driven by 6.1% CAGR | Persistence Market Research

Discover the dynamic world of the surgical dressing market with a comprehensive market overview. Explore key statistics, technology trends, market…

Earnings week ahead: Tesla, Netflix, AT&T, Johnson & Johnson, GE and more

…

Wochenausblick - Die Quartalssaison steht in den Startlöchern.

WerbungZum Start in die neue Börsenwoche informieren wir jeden Sonntag über Wirtschaftsdaten, Quartalszahlen und mehr. Neben den Quartalszahlen von Netflix,…

Johnson & Johnson wins full FDA approval for bladder cancer therapy Balversa

…

Top 5 Life Science ETFs

Taking a position in a life science exchange-traded fund (ETF) provides exposure to a basket of stocks focused on the…

Johnson & Johnson likely to post dip in 4Q earnings

Johnson & Johnson (NYSE:JNJ) raised its full-year guidance after a strong third quarter which saw earnings beat expectations and its…

Johnson & Johnson: Is The Dividend Still Safe After The Kenvue Split-Off?

…

Johnson & Johnson: One Penny, Per Hour, Forever

…

S&P 500 zum Teil geschlagen: 15 Dividendenkönige, die seit 60 Jahren oder mehr ihre Ausschüttungen erhöhen

Diese 15 Aktienunternehmen, darunter Namen wie Procter & Gamble und Johnson & Johnson, haben ihre Dividenden seit mehr als 60…

The Zacks Analyst Blog Highlights Johnson & Johnson, Micron Technology, The Southern Company, TotalEnergies and PACCAR

Johnson & Johnson, Micron Technology, The Southern Company, TotalEnergies and PACCAR are part of the Zacks top Analyst Blog.…

Johnson & Johnson-Aktie mit leichten Kursgewinnen (147,4645 €)

Die Aktie von Johnson & Johnson notiert heute etwas fester. Zuletzt zahlten Investoren für das Papier 161,77 US-Dollar. Am Aktienmarkt…

Is Johnson & Johnson Stock a Buy Now?

The pharmaceutical giant recently announced another acquisition.…

Is Johnson & Johnson Stock a Buy Now? @themotleyfool #stocks $JNJ

The pharmaceutical giant recently announced another acquisition.…

Top Analyst Reports for Johnson & Johnson, Micron Technology & Southern Company

Todays Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Micron Technology, Inc. (MU)…